Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 4Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 4

Conditions

Breast Neoplasms 6392Neoplasms 5365Prostatic Neoplasms 2966Carcinoma, Non-Small-Cell Lung 2709Colorectal Neoplasms 2679Lung Neoplasms 2267Multiple Myeloma 1663Lymphoma 1600Neoplasm Metastasis 1552Leukemia, Myeloid, Acute 1540Melanoma 1486Pancreatic Neoplasms 1470Ovarian Neoplasms 1423Leukemia 1389Head and Neck Neoplasms 1284Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1129Leukemia, Lymphocytic, Chronic, B-Cell 1090Brain Neoplasms 1050Rectal Neoplasms 980Lymphoma, Follicular 979Recurrence 976Uterine Cervical Neoplasms 926Glioblastoma 920Carcinoma, Renal Cell 882Lymphoma, Large B-Cell, Diffuse 853Hodgkin Disease 777

Interventions

liposomal doxorubicin 1Trabectedin 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Ovarian Epithelial Cancer Recurrent × Clear all
NCT02735928 2023-11-15

PARROT

Catholic University of the Sacred Heart

Phase NA Completed
40 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT02394015 2020-03-27

RETRO-ROC

Grupo Español de Investigación en Cáncer de Ovario

Completed
90 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT02260544 2016-09-23

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Dr. Reddy's Laboratories Limited

Phase 1 Completed
49 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT02026921 2014-01-03

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Phase 2 Completed
74 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡